🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-dose, open-label, two part, parallel group study. This stu...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05-28
Trial ID
NCT01827657
Treatments Being Tested
The purpose of this study is to explore the efficacy and safety of TMC64705...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01724086
Treatments Being Tested
The purpose of the study is to investigate the safety, tolerability, and ph...
Status
Completed
Location
Multiple Locations
Start Date
2013-10
Trial ID
NCT02018536
This study is a three Part, Phase 1, randomized, dose-escalation, fusion, p...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-11-03
Trial ID
NCT01277692
GSK2336805 is a hepatitis C virus (HCV) NS5A inhibitor being developed for ...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-07-07
Trial ID
NCT01439373
Treatments Being Tested
GSK2336805 is a novel hepatitis C virus (HCV) non-structural 5A (NS5A) inhi...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-01
Trial ID
NCT01648140
Treatments Being Tested
This study is a Phase I open label drug interaction study to evaluate the e...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-09-27
Trial ID
NCT01458054
This is a single-center, randomized, two part, double-blind, crossover stud...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-09-01
Trial ID
NCT01424540
Treatments Being Tested